Study reveals hidden risks of mixing Beta-Blockers and Anti-Inflammatories
NCT ID NCT06566794
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how two common drugs—carvedilol (for heart conditions) and diclofenac (a painkiller)—change the way the body processes other medications. Twelve healthy volunteers took a mix of test drugs with either carvedilol, diclofenac, or a placebo. The goal was to see if these drugs slow down key liver enzymes, which could lead to dangerous drug interactions. The results will help doctors prescribe safer combinations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG INTERACTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Clinical Pharmacology
Helsinki, Finland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Pfizer tests experimental drug to slow stomach emptying in obesity
- New Gel's drug interactions revealed in healthy volunteer study
- New computer tool aims to catch dangerous drug mixes in older patients
- Gene study aims to predict chemo side effects in kids with leukemia
- New study aims to predict dangerous side effects of common breast cancer drugs
- 12 healthy volunteers test drug combo in Early-Stage study